AHPI accuses insurers of cartelisation, prompting Bajaj Allianz cashless suspension and market share falls.

• AHPI may seek regulator intervention, alleging fixed tariffs violate competition rules, possibly involving a CCI investigation.
• Bajaj Allianz policyholders could lose cashless treatment from September 1 across 15,000 hospitals, impacting patients.
• PBFI’s revenue may drop as policy sales on its platform suffer from insurer disruptions significantly.